Health Technology Kobayashi Pharmaceutical Co., Ltd. Business Summary
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Financial Highlights
Dec 2020
JPY USD Revenue 150,514M 1,409.72M Gross Profit 84,125M 787.91M Operating income 25,809M 241.72M Income before tax 26,635M 249.46M Net income 19,205M 179.87M EBITDA 29,915M 280.18M Diluted EPS 245.70 2.30 Dividends Per Share 77 0.72 Total Assets 238,366M 2,308.74M Total liabilities 55,781M 540.27M Total equity 182,583M 1,768.44M Operating cash flow 23,986M 224.65M Currency in JPY Currency in USD
Historical Data Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Revenue
160,067.59M
156,761M
167,479M
158,340M
150,514M
Gross Profit
93,833.09M
94,189M
101,963M
89,689M
84,125M
Operating income
23,097.27M
22,809M
26,191M
25,512M
25,809M
Income before tax
26,402.60M
22,572M
25,304M
26,804M
26,635M
Net income
19,094.61M
15,863M
18,023M
19,139M
19,205M
EBITDA
26,598.60M
26,328M
29,594M
29,639M
29,915M
Diluted EPS
237.21
201.02
227.95
244.07
245.70
Dividends Per Share
100
58
66
73
77
Total Assets
201,234M
218,831M
228,787M
233,732M
238,366M
Total liabilities
57,914M
65,016M
62,536M
61,072M
55,781M
Total equity
143,320M
153,811M
166,249M
172,657M
182,583M
Operating cash flow
16,097M
22,350M
20,007M
20,089M
23,986M
Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Revenue
1,473.12M
1,397.98M
1,516.43M
1,452.51M
1,409.72M
Gross Profit
863.55M
839.97M
923.21M
822.75M
787.91M
Operating income
212.56M
203.40M
237.14M
234.03M
241.72M
Income before tax
242.98M
201.29M
229.11M
245.88M
249.46M
Net income
175.72M
141.46M
163.18M
175.56M
179.87M
EBITDA
244.78M
234.79M
267.95M
271.89M
280.18M
Diluted EPS
2.18
1.79
2.06
2.23
2.30
Dividends Per Share
0.92
0.51
0.59
0.66
0.72
Total Assets
1,725.33M
1,942.57M
2,085.28M
2,150.74M
2,308.74M
Total liabilities
496.54M
577.15M
569.98M
561.96M
540.27M
Total equity
1,228.79M
1,365.38M
1,515.28M
1,588.74M
1,768.44M
Operating cash flow
148.14M
199.31M
181.15M
184.28M
224.65M
Valuation Measures
Dec 2020
PER 51.32 ROA 8.13% ROE 10.81% Operating margin 17.14% Profit margin 12.75%
Key executives
President & Representative Director:
Akihiro Kobayashi
Manager-Finance & Accounting:
Noriaki Hirao
Executive Officer & General Manager-Manufacturing:
Tetsuji Nishioka
Executive Officer & Manager-Healthcare Business:
Fujito Owaki
Executive Officer & Manager-Mail Order Sales:
Yoshihiro Ogawa Shareholders
KOBAYASHI AKIHIRO /KOBAYASHI PHARMACEUTICAL/ (11.2%)
Kobayashi Foundation (7.3%)
MFS International (UK) Ltd. (5.4%)
Kobayashi Pharmaceutical Co., Ltd. (4.7%)
WATANABE IKUKO (2.9%)
Ohtori Ltd. (2.6%)
MIYATA FAMILY /KOBAYASHI PHARMACEUTICAL/ (2.5%)
IUE YUKAKO (2.2%)
Nomura Asset Management Co., Ltd. (2.2%)
Kobayashi Pharmaceutical Business Association (1.8%)
Contact Details Website: http://www.kobayashi.co.jp Address:
KDX Kobayashi Doshomachi Building,
4-4-10 Dosho-machi,
Osaka,
541-0045,
Japan
Phone:
+81.6.6231.1144
Related Companies
Jiangsu Kobayashi Pharmaceutical Co. Ltd.
True Nature KK
Kobayashi Pharmaceutical Aoitori Foundation
Kobayashi America Manufacturing LLC
Hefei Kobayashi Daily Chemicals Co. Ltd.
PT Kobayashi Pharmaceutical Indonesia
Kobayashi Healthcare LLC
Kobayashi Healthcare (Malaysia) Sdn. Bhd.
Kobayashi Pharmaceutical (Taiwan) Co. Ltd.
Kobayashi Healthcare of America, Inc.
Shanghai Kobayashi Pharmaceutical Business Co. Ltd.
Hefei Kobayashi Daily Products Co. Ltd.
KOBAYASHI Healthcare (Thailand) Co. Ltd.
PT Kobayashi Eglin
KOBAYASHI Pharmaceutical (Singapore) Pte Ltd.
Kobayashi Pharmaceutical (Hong Kong) Co. Ltd.
Kobayashi Healthcare Australia Pty Ltd.
Kobayashi Healthcare Europe Ltd.
Rokuyou-Seiyaku, Inc.
Kobayashi Medical America LLC
Meitan Hompo KK
Kobayashi Pharmaceutical Business Association
Ehime Kobayashi Pharmaceutical Co. Ltd.
Kobayashi Pharmaceutical Distribution Co. Ltd.
Kobayashi Pharmaceutical Plax Co. Ltd.
Suehiro Sangyo Co. Ltd.
Kobayashi Pharmaceutical of Toyama Co. Ltd.
Sendai Kobayashi Pharmaceutical Co. Ltd.
Juju Cosmetics Co., Ltd.
Heatmax, Inc.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 17 Sep, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
